Campbell & CO Investment Adviser LLC Acadia Pharmaceuticals Inc Transaction History

Campbell & CO Investment Adviser LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$14.62 - $18.42 $528,103 - $665,367	36,122 New	36,122 $586,000
Q4 2023 Feb 13, 2024	BUY	$20.78 - $31.77 $1.4 Million - $2.14 Million	67,342 New	67,342 $2.11 Million
Q2 2023 Aug 11, 2023	BUY	$17.8 - $25.65 $278,018 - $400,627	15,619 New	15,619 $374,000
Q4 2021 Feb 10, 2022	SELL	$16.79 - $27.09 $256,047 - $413,122	-15,250 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$15.78 - $24.77 $240,645 - $377,742	15,250 New	15,250 $253,000
Q3 2020 Oct 15, 2020	SELL	$36.42 - $57.0 $166,840 - $261,117	-4,581 Closed	0 $0
Q2 2020 Jul 29, 2020	BUY	$39.26 - $52.73 $179,850 - $241,556	4,581 New	4,581 $222,000
Q1 2020 Apr 29, 2020	SELL	$31.65 - $46.87 $159,516 - $236,224	-5,040 Closed	0 $0
Q4 2019 Jan 23, 2020	SELL	$36.21 - $51.4 $403,850 - $573,264	-11,153 Reduced 68.88%	5,040 $216,000
Q3 2019 Oct 16, 2019	BUY	$22.22 - $44.01 $359,808 - $712,653	16,193 New	16,193 $583,000

279

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.76B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Campbell & CO Investment Adviser LLC, based on Form 13F filings with the SEC.

Stay updated on Campbell & CO Investment Adviser LLC with notifications on news.